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Background: To evaluate immunisation coverage, timeliness and predictors of delayed receipt in urban Australian
Indigenous children during the first 18 months of life.
Methods: Cross-sectional retrospective analysis of data collected from 140 Australian Indigenous children aged <
5 years at the time of enrolment in a prospective cohort study on respiratory illness between 14 February 2013 and
28 January 2015. Children were recruited through an urban community primary health care centre in the Northern
suburbs of Brisbane, Queensland.
Results: The proportion of children with completed immunisation schedules was 50 of 105 (47.6%) at 7 months,
30 of 85 (35.3%) at 13 months and 12 of 65 (18.5%) at 19 months. Timely receipt of diphtheria-tetanus-pertussis
decreased from 78.4% at 2 months of age to 63.7 and 59.3% at 4 and 6 months respectively. Amongst the 105
parents/guardians with children ≥7 months at enrolment, 71 (67.6%) incorrectly reported their child’s immunisation
status. Delayed vaccine receipt was significantly associated (p ≤0.05) with having multiple children in the household,
mother’s unemployment and premature birth.
Conclusions: Coverage and timeliness among this population is suboptimal and decreases as children age. Parent/
guardian reporting of vaccination status was unreliable. Children of unemployed mothers and those with multiple
siblings should be targeted to improve community immunisation timeliness due to a greater risk of vaccination delay.
High quality trials, conducted in several settings to account for the diversity of Australian Indigenous communities are
urgently needed to identify culturally appropriate, effective and sustainable strategies to improve immunisation targets
in children.
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Vaccine timeliness, important for early individual protec-
tion and generation of herd immunity [1], is particularly
crucial in infancy [2] and settings with high infection
rates (e.g. Indigenous communities). Australian Indigenous
Australian children experience higher notification and hos-
pitalisation rates for vaccine preventable infections and dis-
eases than non-Indigenous children [3–6]. Furthermore,
some infections pose a greater risk of severe disease and* Correspondence: y.lovietoon@qut.edu.au
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In 2013, national vaccination coverage at 12, 24 and
60-months was 86.0, 92.0 and 93.0% respectively among
Indigenous children, and 90.6, 92.1 and 91.6% among
non-Indigenous children [5]. Although these are applauded,
reporting coverage at these milestones can conceal overdue
vaccination occurring before these milestones [7, 8] and
data reported at a national level does not account for the
heterogeneity of Australian Indigenous communities. A
number of Australian studies have now highlighted the
gap in timely immunisation between Indigenous and
non-Indigenous children, including regional differences,le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Table 1 Antigens recommended for Indigenous children across
all QLD Immunisation Program Schedules used from 2008–2015
Age vaccine is due Antigen
2, 4 & 6 months Diphtheria, Tetanus, Pertussis (DTP)
Polio
Hepatitis B (HepB)
Haemophilus influenza type b (Hib)
Rotavirus (Rota)
Pneumococcal (PCV)
12 months Measles, mumps, rubella (MMR)
Haemophilus influenza type b (Hib)
Meningococcal C (MenC)
18 months Varicella
Hepatitis A (HepA)
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data indicates that the gap in timeliness remains, with
the proportion of delayed receipt being 5.8-21.6 per-
centage points higher among Indigenous children com-
pared to non-Indigenous children for selected vaccines
(3rd dose of diphtheria-tetanus-pertussis (DTP) and 1st
and 2nd dose of measles-mumps-rubella (MMR) [5].
However there are limited current data on whether this
gap exists among other vaccines and at earlier time
points. There are also little data on differences in cover-
age within and between Indigenous communities and
on predictors of incomplete coverage and timeliness in
this population that account for its diversity. Availabil-
ity of such data would inform a targeted approach and
potentially influence policy in our era of limited health
resources.
Our primary objective was to evaluate vaccination
coverage and timeliness during the first 18-months of
life among a cohort of urban Indigenous children. Our
secondary objectives were to: a) identify potential predic-
tors of delayed vaccination, and; b) evaluate the validity
of parent/carer report of child immunisation status.
Methods
This study was conducted in an urban community pri-
mary health care centre in the Northern suburbs of
Brisbane, Queensland. The centre opened in 2011 and has
over 10,000 registered clients. Approximately 65% iden-
tify as Aboriginal and/or Torres Strait Islander, which
approximates to 14% of the Brisbane’s Indigenous
population based on the most recent census data [11].
This paper reports on results from a retrospective ana-
lysis of children at the time of enrolment into a prospective
cohort study of paediatric acute respiratory illnesses (ARI)
currently underway at the centre [12]. Children presenting
to the centre for any reason, including accompanying
another person, are invited to participate. Children are
eligible for participation if they are aged < 5 years at time
of enrolment, registered as a patient with the clinic and
intend to remain in the study area for the following
12 months. Written consent is obtained from the par-
ent(s)/guardian(s) before study entry. Ethical approval
was obtained from the Queensland Children’s Health
Services (HREC/12/QRCH/169) and the Queensland
University of Technology (1300000741) Human Research
Ethics Committees. Additionally, this study was conducted
in accordance with the guidelines for ethical conduct in
Aboriginal and Torres Strait Islander Health Research
outlined by the Australian National Health and Medical
Research Council [13] and the cultural oversight was
provided by an Indigenous Reference Group. Indigenous
children enrolled prior to 28 January 2015 were included
in this analysis. As per national standards, Indigenous sta-
tus was determined through self-report [14]. Of all thechildren aged < 5 years registered in the clinic during the
study period, 16.3% participated in this study.
Parent/guardian-reported demographic, infant, maternal
and paternal characteristics were collected at baseline.
Parent/guardian report of their child’s immunisation sta-
tus was collected by asking “Is your child age appropri-
ately immunised for childhood vaccines?”. With parent/
guardian consent, immunisation records were retrieved
from the Australian Childhood Immunisation Register
(ACIR). ACIR is a nationwide opt-out register charac-
terised by incentivised reporting of vaccine administration
by immunisation providers. Inclusion in ACIR is based on
one’s enrolment in Australia’s universal health care
scheme, of which 99% of Australians are enrolled in by
12 months of age [5].
During the period in which the study participants were
born (2008–2014), there were multiple changes to the
Immunisation Program Schedule for Queensland [15].
Therefore our analysis was conducted according to anti-
gens, opposed to vaccines. Only those antigens that were
recommended for Indigenous children at the same time
points across all five schedules (Table 1) were included
in our analysis. The series of vaccines due at 2, 4 and
6 months are henceforth referred to as the ‘primary
series’ of vaccines.
In Queensland, the majority of vaccines administered
to infants and young children are administered by general
practitioners through primary health care centres. Some
local government areas also provide public immunisation
clinics. Vaccines given at birth (e.g. Bacillus Calmette–
Guérin) are routinely received through hospitals and fre-
quently recorded in a different system to ACIR. Therefore
birth vaccines were excluded from all analyses.
Immunisation coverage and timeliness was calculated
using only those vaccines received prior to or on the
date of enrolment. Children were included in the cover-
age and timeliness calculations at each milestone if, at
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the respective milestone. This allowed for vaccines ad-
ministered within 1 month of the vaccine due date to be
included in the analyses.
The Australian National Centre for Immunisation Re-
search and Surveillance routinely allows a 3-month lag
period between vaccine receipt and report to ACIR [5].
Therefore, we only analysed vaccines that were due to
have been received ≥3 months prior to the date we ex-
tracted immunisation records from ACIR. Immunisation
timeliness was classified according to the differences in
weeks between the dates at which vaccines were due and
actually received. There is no universally accepted defin-
ition of vaccine timeliness. Australian studies typically
define timely receipt as received ≤30 days after the vac-
cine due date and delayed as >30 days after the due date
[5, 7, 10]. Therefore timeliness was classified using the
following definitions:
a) Early (received >14 days before due date)
b) No delay (received between 14 days before and
30 days after due date)
c) Delayed (received >30 days after the due date)
d) Not received (no recorded dose prior to enrolment
date)
e) Incorrectly received (vaccine received when not
due/eligible)
The third dose assumption was not applied to the
treatment of ACIR data in this study. This assumes that
where there is a record of a second or third dose of a
vaccine being received the previous dose has also been
received, regardless of whether there is a record of it
[16]. We assumed that the first record of any vaccination
on ACIR was the first dose and checked the effect of
that assumption by evaluating the number of children
for whom a third dose assumption would have been ap-
plied if we had taken that approach.
Statistical analysis
Child characteristics at enrolment and vaccination data
were tabulated and expressed as proportions and/or
mean/medians with the corresponding 95% Confidence
Intervals (CI) or Interquartile Ranges (IQR). To identify
potential predictors of vaccination delay, exploratory uni-
variate analyses were performed with timeliness recoded
as a dichotomous variable with ‘delayed’ or ‘not received’
being classified as ‘delayed’, and ‘early’ or ‘no delay’ being
classified as ‘no delay’. Children with responses of ‘un-
known’, ‘not applicable’ or ‘declined to answer’ for any of
the predictor variables were excluded from the analysis.
The predictor variables ‘participating health care service is
usual provider’ and ‘multiple birth’ were excluded from
the analyses as more than 90% of participants reportedthe same response. The analysis of predictors of timeli-
ness was only performed for the DTP vaccines, given
its consistency in the primary series across all vaccine
schedules. A two-tailed p-value of <0.05 was considered
significant. All analyses were performed in Stata V13
(StataCorp, Texas, USA).Results
Between 14 February 2013 and 28 January 2015, 140 chil-
dren were enrolled; median age at enrolment of 18.3 months
(IQR 6.9–32.0). ACIR records were unavailable for four par-
ticipants who were excluded from further analyses. Of the
remaining 136 children, 71 (50.7%) were male. Child char-
acteristics and that compared to national Aboriginal and
Torres Strait Islander population (where data are available)
are provided in Table 2.
Immunisation coverage at the selected milestones was
low among all age groups, and decreased in older chil-
dren (Table 3). To consider the effect of the upper age
restriction of rotavirus vaccines on overall coverage,
coverage was recalculated excluding this antigen. The in-
crease in coverage through the exclusion of rotavirus
was by less than 10 percentage points at each milestone.
Vaccine receipt and timeliness are presented in Table 4
for each antigen and dose. The highest proportions of
non- receipt were for the rotavirus vaccine due at 4
(26.7%) and 6-months (42.9%) and the HepA vaccine
due at 18-months (23.1%). Among the primary series of
immunisations, the proportion of the cohort who had
received each vaccine decreased at each milestone.
The proportion of children who received a vaccine
earlier than recommended was ≤2% for most vaccines
and 5.1% for the varicella vaccine at 18-months (Table 4).
Among those children who received the primary series,
most (58.7–89.7%) received them with no delay (Fig. 1);
this was not the case at 12 and 18-months of age. MMR
due at 12-months and HepA due at 18-months had the
highest rates of delayed receipt (53.7 and 72.0% respect-
ively). Interestingly, there were notable variations in the
proportions of receipt and timely receipt among the three
vaccines due at 12 months, and more pronounceably
among the two vaccines due at 18 months. Rotavirus
vaccinations at 2, 4 and 6-months had the lowest rates
of delayed receipt (9.3, 20.5 and 16.7% respectively).
For those vaccines that were delayed, the median number
of weeks delayed ranged from 1.4 to 19.2 weeks, with rota-
virus vaccines having the shortest median delay and vac-
cines due at 18 months having the longest median delay.
There were 6 instances where vaccinations were ‘incor-
rectly received’ either because the child was not due or
was no longer eligible to receive the vaccine. The majority
of these instances (4/6) were due to rotavirus being ad-
ministered outside the recommended age cut-offs.
Table 2 Demographic, infant, maternal and paternal
characteristics of study population
Characteristic N = 140
n (%)
National Indigenous
population (%)
Sex
Male 71 (50.7) 50.9 [27]
Female 69 (49.3) 49.1 [27]
Care type
Both parents 80 (57.1) 54.7 [28]
Single parent 51 (36.4) 45.3 [28]
Othera 8 (5.7)
Missing 1 (0.7)
Primary carer
Mother 115 (82.1)
Otherb 16 (11.4)
Missing 9 (6.4)
Childcarec
Yes 35 (25.0) 21.7f [29]
No 104 (74.3)
Missing 1 (0.7)
Study clinic is usual health care provider
Yes 131 (93.6) N/A
No 0 (0.0) N/A
Missing 9 (6.4) N/A
Educational level of father
Did not finish high school 63 (45.0) 58.0g [30]
High school 37 (26.4) 16.0g [30]
Post-school qualificationd 16 (11.4) 25.9g [30]
Missing 24 (17.1)
Educational level of mother
Did not finish high school 54 (38.6)
High school 66 (47.1)
Post-school qualificationd 16 (11.4)
Missing 4 (0.3)
Employment status of father
Employede 60 (42.9) 49.7h [30]
Unemployed 57 (40.7) 50.3h [17]
Missing 23 (16.4)
Employment status of mother
Employede 17 (12.1) 43.0h [30]
Unemployed 121 (86.4) 57.0h [30]
Missing 2 (1.4)
Income level
< $26000 44 (31.4) 35.2i [31]
$26000 - < $52000 56 (40.0) 34.3 i [31]
$52000 - < $78000 23 (16.4) 8.9i [31]
≥ $78000 11 (7.9) 4.0i [31]
Table 2 Demographic, infant, maternal and paternal
characteristics of study population (Continued)
Missing 6 (4.3)
Multiple birth
Singleton 134 (95.7) 98.5j [32]
Multiple 1 (0.7) 1.5j [32]
Missing 5 (3.6)
Mdn (IQR) Mean/Mdn
Number of children in household
(N = 138)
2.0 (3.0-1.0)
Age of mother at birth of child
(in years) (N = 138)
24.0 (29.0-20.0) 25.2k [33]
Age of father at birth of child
(in years) (N = 135)
26.0 (33.0-23.0) 27.9k [33]
Gestational age (in weeks)
(N = 137)
40.0 (40.0-38.0) 38.2m [33]
Birth weight (in grams) (N = 137) 3200.0 (3628.0-
2770.0)
3200 m [33]
aOther = shared, other relative, other non-family member (including government
care); bOther = Father, Mother and Father, Grandparent, Grandparent and Father,
Other non-family; cChildcare = formal regulated daytime care provided in a group
setting, includes private or community centres and family day care; dPost-school
qualification = Certificate, Diploma, Bachelor Degree; eEmployed = Full Time, Part
Time, Casual; fIncludes children aged 0–4 years exclusively attending formal
childcare and children aged 0–4 years attending both formal and informal
childcare; gData represents both males and females; hUnemployed = those
not participating in the labour force and those participating in the labour
force but without work; iCategories of income levels presented for national
data differ from categories used in study and are as follows: <$20800,
$20800- < $52000, $52000- < $78000, ≥$78000; jData represents all Australian
women, not solely Indigenous Australian women; kMedian value; mMean
value
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≥7-months at enrolment reported that their child was
up-to-date (96/105, 91.4%). However parent/guardian
report was not consistent with ACIR; 71.9% of par-
ents/guardians with who considered their child was up-
to-date were incorrect compared to ACIR. Sensitivity
and specificity of parental report was 93.1 and 9.2%
respectively.
Univariate unadjusted analyses of the associations be-
tween child characteristics and delayed receipt of DTP
at 2, 4 and 6-months, as well as delayed receipt at any
time point, are presented in Table 5. There was a signifi-
cant association (p < 0.05) between delayed receipt and
the mother being unemployed at any time point (OR 6.6,
95% CI 1.37, 63.51). Delayed receipt was also significantly
associated with having other children in the household at
any time point, compared to no other children (1–2 other
children OR 4.54, 95% CI 1.52–13.55, ≥3 other children
OR 4.31, 95% CI 1.29, 14.37). Being born premature
(<37 weeks gestation) was significantly decreased the odds
of delayed vaccine receipt at 2 months of age (OR 0.15,
95% CI 0–0.96). There was likely to be insufficient
Table 3 Coverage of children fully immunised at date of their enrolment
Age Eligible children
N
Children fully immunised
n (%, 95% CI)
Children fully immunised, excluding rotavirus vaccine.
n (%, 95% CI)
7 monthsa 105 50 (47.6, 37.9–57.3) 57 (54.3, 44.6–64.0)
13 monthsb 85 30 (35.3, 24.9–45.7) 35 (41.2, 30.5–51.6)
19 monthsc 65 12 (18.5, 8.8–28.2) 14 (21.5, 11.3–31.8)
aFully immunised at 7 months = 3 doses of each of DTP, hib, polio, PCV, hepB and rotavirus; bFully immunised at 13 months = 3 doses of each of DTP, polio, PCV,
hepB and rotavirus, 4 doses of hib, 1 dose of MMR and 1 dose of menC; cFully immunised at 19 months = 3 doses of each of DTP, polio, PCV, hepB and rotavirus,
4 doses of hib, 1 dose of MMR, 1 dose of menC, 1 dose of varicella and 1 dose of hepA
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and multivariate regression was therefore not performed.
Discussion
We examined immunisation coverage and timeliness in
a cohort of urban Indigenous children. According to
participants’ ACIR records, less than half of the children
aged ≥ 7, 13 or 19-months were up-to-date at enrolment
into the cohort study. Delays in vaccine receipt increased as
infants aged and parent/guardian reporting of vaccination
status was unreliable. Given the higher incidence of vaccine
preventable diseases in Indigenous children [3], and the im-
portance of herd immunity, our data provide further sup-
port for the need to identify evidence-based strategies to
improve timeliness [17] among this population.
Our results are consistent with a Northern Territory
(NT) cohort study [9] that reported coverage of theTable 4 Proportions of vaccine receipt and timeliness amongst elig
Vaccine Eligible childrena
N (%)
Total not received
N (%)
PCV 1 (2 months) 126 (90.0) 1 (0.8)
PCV 2 (4 months) 120 (85.7) 7 (5.8)
PCV 3 (6 months) 105 (75.0) 13 (12.4)
DTP, polio & HepB 1 (2 months) 126 (90.0) 1 (0.8)
DTP, polio & HepB 2 (4 months) 120 (85.7) 7 (5.8)
DTP, polio & HepB 3 (6 months) 105 (75.0) 14 (13.3)
Hib 1 (2 months) 126 (90.0) 1 (0.8)
Hib 2 (4 months) 120 (85.7) 7 (5.8)
Hib 3 (6 months) 105 (75.0) 14 (13.3)
Rota 1 (2 months) 126 (90.0) 19 (15.1)
Rota 2 (4 months) 120 (85.7) 32 (26.7)
Rota 3 (6 months) 105 (75.0) 45 (42.9)
MMR (12 months) 85 (60.7) 3 (3.5)
MenC (12 months) 85 (60.7) 4 (4.7)
Hib 4 (12 months) 85 (60.7) 13 (15.3)
Varicella (18 months) 65 (46.4) 6 (9.2)
HepA (18 months) 65 (46.4) 15 (23.1)
aEligibility for 2 month vaccines = child ≥ 3 months of age at enrolment, eligibility fo
6 month vaccines = child ≥ 7 months of age at enrolment, eligibility for 12 month v
vaccines = child ≥ 19 months of age at enrolmentprimary series (also at 7-months of age) as 45.2%; coverage
in this NT cohort was lower amongst children living in
urban areas compared to remote areas. The authors sug-
gested the reasons for the regional differences were likely
related to differences in health service delivery and/or
population movement between urban and remote areas.
The proportion of timely immunisation of DTP in our co-
hort also falls within the ranges reported in an analysis of
immunisation from 31 low and middle income countries
[1] in which the timeliness of DTP was 67% (11.6–89.3%)
for the first dose and 41% (10.8–82.1%) for the third dose.
The proportions of our cohort with delayed receipt of
DTP3 (39.9%) and PCV3 (40.2%) are comparable to na-
tional timeliness data of these vaccines (38.2% and 40.5%
for DTP3 and PCV3 respectively) [5], however delayed re-
ceipt of MMR at 12 months was higher in our cohort com-
pared to national data (53.7% vs 40.3%).ible children
Total received
N (%)
No delay
N (%)
Early
N (%)
Delayed
N (%)
Median number of
weeks delayed
Mdn (IQR)
125 (99.2) 99 (79.2) 1 (0.8) 25 (20.0) 9.1 (17.6-1.3)
113 (94.2) 72 (63.7) 0 (0.0) 41 (36.3) 7.4 (16.4-3.4)
92 (87.6) 54 (58.7) 1 (1.1) 37 (40.2) 10.4 (26.1-5.1)
125 (99.2) 98 (78.4) 1 (0.8) 26 (20.8) 9.0 (18.0-1.3)
113 (94.2) 72 (63.7) 0 (0.0) 41 (36.3) 7.4 (16.4-3.4)
91 (86.7) 54 (59.3) 1 (1.1) 36 (39.6) 10.5 (24.9-3.9)
125 (99.2) 98 (78.4) 1 (0.8) 26 (20.8) 9.0 (18.0-1.3)
113 (94.2) 72 (63.7) 0 (0.0) 41 (36.3) 7.4 (16.4-3.4)
91 (86.7) 54 (59.3) 1 (1.1) 36 (39.6) 10.5 (24.9-3.9)
107 (84.9) 96 (89.7) 1 (0.9) 10 (9.3) 1.4 (12.7-1.0)
88 (73.3) 70 (79.5) 0 (0.0) 18 (20.5) 2.9 (5.9-1.0)
60 (57.1) 49 (81.7) 1 (1.7) 10 (16.7) 1.4 (2.3-0.7)
82 (96.5) 38 (46.3) 0 (0.0) 44 (53.7) 7.4 (15.9-3.4)
81 (95.3) 38 (44.7) 0 (0.0) 43 (50.6) 7.3 (15.0-3.4)
72 (84.7) 36 (50.0) 0 (0.0) 36 (50.0) 5.8 (10.7-3.1)
59 (90.8) 28 (47.5) 3 (5.1) 28 (47.5) 12.8 (42.3-2.9)
50 (76.9) 13 (26.0) 1 (2.0) 36 (72.0) 19.2 (37.7-4.1)
r 4 month vaccines = child ≥ 5 months of age at enrolment, eligibility for
accines = child ≥ 13 months of age at enrolment, eligibility for 18 month
Fig. 1 Cumulative percent of receipt of DTP due at 2, 4, 6 months among eligible children
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ness decreased as children got older; the proportion of
delayed receipt increased by 19 percentage points be-
tween the first and third dose of DTP. This is consistent
with findings from a study of an urban NSW Indigenous
cohort [10], the NT data [9] and international data [1].
Non-receipt was highest for rotavirus vaccines, likely
due to the upper age restrictions of administering rota-
virus vaccines, and for the HepA vaccine at 18-months
of age. We also identified that rotavirus vaccines were
received after the recommended upper age limit among
some children, potentially increasing the infant’s risk of
intussusception [18]. Hull et al. [19] predicted potential
impacts of these strict age-limits which included lower
coverage of other vaccinations due to non-vaccination of
late presenters, and non-adherence to age cut-offs. Our
results support both of these predictions. Greater atten-
tion needs to be given to appropriate and timely admin-
istration of rotavirus vaccinations and providers may
need to be reminded of the importance of adhering to
the age limits of vaccine receipt.
Previous research suggests Indigenous-specific vaccines
have lower levels of uptake in their target population thanuniversally-recommended vaccines [6]. This was evident
in our study population with a greater proportion of
children receiving the universally recommended varicella
vaccine at 18-months, compared to the Indigenous-
specific HepA vaccine. Proportions of receipt in this co-
hort also differed between the three vaccines due at
12 months. Fragmented vaccine administration has been
identified in previous studies amongst both Indigenous
and non-Indigenous children. Ferson et al., found that
among a cohort of non-Indigenous children, 9.2% of
fully-immunised children had received vaccines due at the
same time on separate occasions [20]. Similarly, O’Grady
et al. [9] found differences in coverage of 7vPCV and DTP
over the time period in which the 7vPCV was introduced
in Australia. Administration of vaccines on separate occa-
sions is reported to be a significant predictor of vaccin-
ation delay [21]. This could have contributed to the high
rates of non-receipt and/or delayed receipt in our study.
Despite national recommendations approving simultan-
eous administration of multiple vaccines, research sug-
gests fragmented vaccine administration is often related
to the advice and practices of immunisation providers
[20, 21]. Further research needs to be conducted to
Table 5 Characteristics associated with delayed receipt of DTP at 2, 4 and 6 months of age
Characteristic 2 months 4 months 6 months Any delayed
Delayed: n/N
(%)
OR (95% CI) p-value Delayed: n/N
(%)
OR (95% CI) p-value Delayed: n/N
(%)
OR (95% CI) p-value Delayed: n/N
(%)
OR (95% CI) p-value
Sex
Male 16/64 (25.0) 29/61 (47.5) 28/52 (53.8) 36/65 (55.4)
Female 11/62 (17.7) 0.65 (0.27–1.53) 0.32 19/59 (32.2) 0.52 (0.25–1.10) 0.09 22/53 (41.5) 0.61 (0.28–1.32) 0.21 25/61 (41.0) 0.56 (0.28–1.13) 0.12
Care type
Both parents 17/69 (24.6) 28/67 (41.8) 30/59 (50.8) 33/68 (48.5)
Single parent 9/48 (18.8) 0.71 (0.25–1.89) 0.60 19/44 (43.2) 1.06 (0.46–2.44) 1.00 18/38 (47.4) 0.87 (0.35–2.13) 0.90 27/50 (54.0) 1.24 (0.56–2.76) 0.69
Othera 1/8 (12.5) 0.44 (0.01–3.85) 0.79 1/8 (12.5) 0.20 (0.00–1.72) 0.21 2/7 (28.6) 0.39 (0.03–2.63) 0.48 1/7 (14.3) 0.18 (0.00–1.61) 0.18
Primary Carer
Mother 25/103 (24.3) 42/98 (42.9) 42/86 (48.8) 52/104 (50.0)
Otherb 2/16 (12.5) 0.45 (0.05–2.17) 0.48 5/15 (33.3) 0.67 (0.21–2.10) 0.49 5/12 (41.7) 0.75 (0.22–2.54) 0.64 5/15 (33.3) 0.50 (0.16–1.56) 0.23
Child care
No 22/90 (24.4) 35/84 (41.7) 34/71 (47.9) 43/90 (47.8)
Yes 5/35 (14.3) 0.52 (0.18–1.49) 0.22 13/35 (37.1) 0.83 (0.37–1.86) 0.65 15/33 (45.5) 0.91 (0.40–2.08) 0.82 17/35 (48.6) 1.03 (0.47–2.25) 0.94
Education level of mother
Did not finish high school 10/51 (19.6) 19/49 (38.8) 23/45 (51.1) 27/51 (52.9)
High school 13/56 (23.2) 1.24 (0.44–3.53) 0.83 21/53 (39.6) 1.04 (0.47–2.30) 0.93 18/45 (40.0) 0.64 (0.28–1.47) 0.29 24/56 (42.9) 0.67 (0.31–1.43) 0.30
Post-school qualificationc 3/15 (20.0) 1.02 (0.16–4.92) 1.00 6/14 (42.9) 1.18 (0.36–3.95) 0.78 6/12 (50.0) 0.96 (0.27–3.42) 0.95 7/15 (46.7) 0.78 (0.25–2.47) 0.67
Education level of father
Did not finish high school 14/57 (24.6) 21/54 (38.9) 25/48 (52.1) 30/56 (53.6)
High school 8/31 (25.8) 1.07 (0.34–3.22) 1.00 14/30 (46.7) 1.37 (0.50–3.72) 0.64 12/26 (46.2) 0.79 (0.30–2.05) 0.63 15/31 (48.4) 0.81 (0.31–2.14) 0.81
Post-school qualificationc 1/14 (7.14) 0.24 (0.01–1.89) 0.28 4/13 (30.8) 0.70 (0.14–2.93) 0.84 5/10 (50.0) 0.92 (0.24–3.59) 0.91 4/13 (30.8) 0.39 (0.08–1.60) 0.23
Employment status of mother
Employedd 1/15 (6.7) 3/14 (21.4) 3/12 (25.0) 2/14 (14.3)
Unemployed 26/109 (23.9) 4.35 (0.60–192.46) 0.23 45/104 (43.3) 2.77 (0.68–16.40) 0.20 46/92 (50.0) 2.97 (0.68–18.14) 0.18 58/110 (52.7) 6.60 (1.37–63.51) 0.01
Employment status of father
Employedd 11/53 (20.8) 19/49 (38.8) 19/43 (44.2) 22/52 (42.3) 1.74 (0.79–3.80) 0.17
Unemployed 13/51 (25.5) 1.31 (0.52–3.26) 0.57 22/49 (44.9) 1.29 (0.58–2.88) 0.54 24/43 (55.8) 1.60 (0.68–3.74) 0.28 28/50 (56.0) 0.73 (0.42–1.27) 0.27
Number of other children in household
0 3/26 (11.5) 5/23 (21.7) 5/19 (26.3) 5/24 (20.8)
1–2 17/68 (25.0) 2.53 (0.64–14.81) 0.25 30/66 (45.5) 3.00 (1.00–9.04) 0.05 31/59 (52.5) 3.10 (0.99–9.71) 0.05 37/68 (54.4) 4.54 (1.52–13.55) 0.01
3+ 7/30 (23.3) 2.30 (0.45–15.49) 0.43 13/29 (44.8) 2.93 (0.85–10.02) 0.09 12/25 (48.0) 2.58 (0.71–9.37) 0.15 17/32 (53.1) 4.31 (1.29–14.37 0.02
Lovie-Toon
et
al.BM
C
Public
H
ealth
 (2016) 16:1159 
Page
7
of
11
Table 5 Characteristics associated with delayed receipt of DTP at 2, 4 and 6 months of age (Continued)
Income level
< $26,000 8/42 (19.0) 19/40 (47.5) 20/35 (37.7) 28/44 (63.6)
$26,000–≤ $52,000 15/49 (30.6) 1.86 (0.64–5.79) 0.31 20/47 (42.6) 0.82 (0.32–2.08) 0.81 18/40 (45.0) 0.62 (0.22–1.68) 0.41 22/49 (44.9) 0.47 (0.19–1.16) 0.11
$52,000–≤ $78,000 3/21 (14.3) 0.71 (0.11–3.46) 0.93 6/19 (31.6) 0.52 (0.13–1.82) 0.38 8/18 (44.4) 0.61 (0.16–2.18 0.56 7/19 (36.8) 0.34 (0.09–1.16) 0.09
> $78,000 1/9 (11.1) 0.54 (0.01–5.13) 0.99 2/9 (22.2) 0.32 (0.03–1.98) 0.31 2/7 (28.6) 0.31 (0.03–2.21) 0.33 2/9 (22.2) 0.17 (0.02–1.03) 0.06
Father’s age at birth of child
< 20 years 2/7 (28.6) 3/7 (42.9) 4/7 (57.1) 5/7 (71.4)
20–29 years 16/76 (21.1) 0.67 (0.10–7.66) 0.95 28/71 (39.4) 0.87 (0.14–6.39) 1.00 32/64 (50.0) 0.75 (0.10–4.84) 1.00 37/76 (48.7) 0.38 (0.03–2.52) 0.45
≥ 30 years 8/38 (21.1) 0.67 (0.09–8.32) 0.99 16/37 (43.2) 1.01 (0.15–7.93) 1.00 12/29 (41.4) 0.54 (0.07–3.84) 0.74 17/38 (44.7) 0.33 (0.03–2.34) 0.38
Mother’s age at birth of child
< 20 years 6/28 (21.4) 11/27 (40.7) 14/26 (53.8) 14/28 (50.0)
20–29 years 16/67 (23.9) 1.15 (0.36–4.08) 1.00 25/63 (39.7) 0.96 (0.35–2.69) 1.00 27/55 (49.1) 0.83 (0.29–2.33) 0.87 34/67 (50.7) 1.03 (0.43–2.49) 0.95
≥ 30 years 4/29 (13.8) 0.59 (0.11–2.88) 0.68 11/28 (39.3) 0.94 (0.28–3.17) 1.00 7/22 (31.8) 0.41 (0.10–1.51) 0.21 11/29 (37.9) 0.61 (0.21–1.75) 0.36
Gestational age
≥ 37 weeks gestation 26/108 (24.1) 44/103 (42.7) 44/91 (48.4) 55/108 (50.9)
< 37 weeks gestation 0/15 (0.0) 0.15 (0–0.96) 0.04 3/14 (21.4) 0.37 (0.06–1.51) 0.21 4/11 (36.4) 0.61 (0.12–2.61) 0.67 4/15 (26.7) 0.35 (0.08–1.29) 0.13
Birthweight
≥ 2500 grams 25/103 (24.3) 42/98 (42.9) 43/87 (49.4) 53/103 (51.5)
< 2500 grams 1/20 (5.0) 0.17 (0.00–1.15) 0.08 5/19 (26.3) 0.48 (0.12–1.55) 0.27 5/15 (33.3) 0.51 (0.13–1.82) 0.38 6/20 (30.0) 0.40 (0.14–1.13) 0.09
aOther = shared, other relative, other non-family member;bOther = Father, Mother and Father, Grandparent, Grandparent and Father, Other non-family; cPost-school qualification = Certificate, Diploma, Bachelor Degree;
dEmployed = Full Time, Part Time, Casual
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rently occurs in Australia and to understand provider’s
intentions if and when making these recommendations.
We found that parental report of their child’s immun-
isation status over-estimated the proportion of children
up-to-date. Thus, in this community, and potentially
other similar communities, immunisation status should
be confirmed by another source. Possible reasons as to
why parents may believe their children are up-to-date
could include a lack of parental understanding of what
vaccines are required, a lack of personal vaccination re-
cords and/or communication issues between parents
and health providers.
Despite the significant body of evidence indicating the
need to improve timeliness among urban Australian In-
digenous children, there is a lack of studies evaluating
interventions to do this. One Australian study found that
the distribution of personalised calendars to parents
through health clinics was an effective and culturally ap-
propriate way to improve timeliness of the primary
series [22]. Identifying risk factors associated with non-
timeliness may inform appropriate intervention points.
We found that having other children in the household
and a mother who was unemployed were potential predic-
tors of delayed receipt of DTP at 2, 4 and/or 6-months,
whereas prematurity was associated with a decreased odds
of delayed vaccine receipt. . Living in a household with
multiple children has previously been identified as a pre-
dictor of vaccination delay in Australia and internationally
[1, 21, 23, 24], suggesting additional support needs to be
provided for these families. While it could be presumed
that being an unemployed mother may allow for greater
time to have children vaccinated, unemployed mothers
may be more likely to lack other resources such as fi-
nances, transport and social support. Other studies
[21, 23] have identified single-parent households and
low levels of parental education as predictors of de-
layed vaccine receipt, however we were unable to dem-
onstrate these associations with the available data.
The main strength of this study is the use of ACIR re-
cords as the primary measure of a child’s immunisation
status. ACIR records were retrievable for 97% of chil-
dren we recruited. The allowance of 3 months lag be-
tween when the last vaccine in the cohort was due and
the data of retrieval of ACIR records reduced the likeli-
hood that incomplete immunisation records were due to
reporting or processes delays. We did not employ the
third-dose assumption that is routinely used to determine
national immunisation coverage in this study. While
this has been previously reported as a valid assumption
[16, 25], these studies were conducted over a decade ago
making their current applicability questionable, particu-
larly given changes over time from a paper-based submis-
sion system to an electronic one. We could not validatethe third dose assumption with personal health or clinic
records as many of the study children received health
care and vaccines at clinics other than our study site,
particularly the one third (44/140) that were born prior
to the opening of the clinic in July 2011. By using the
3rd dose assumption our analyses would have included
an additional 21 vaccines administered between 8 kids.
Hull and McIntyre [25] calculated that use of the third
dose assumption increased the proportion of children fully
immunised by 11–12%. While this would have raised the
proportion of children fully immunised in our population
to 59.6, 47.3 and 30.5% at 7, 13 and 19 months respect-
ively, these levels remain noticeably below national levels.
Our analyses of potential predictors of timeliness and
coverage were limited by the sample size and that child
characteristics were collected at enrolment, not at the
time vaccines were administered. It is possible that several
of these factors would have changed between vaccine re-
ceipt and enrolment; however our results are consistent
with other studies [1, 26]. Nevertheless comprehensive
prospective studies are needed to confirm predictors of
timely immunisation amenable to intervention. Finally,
due to the retrospective nature of this study and the use
of ACIR records, we were unable to assess to what extent
early or delayed vaccine receipt was an intentional deci-
sion made by the immunisation provider and/or family.Conclusions
Immunisation coverage and timeliness in this population
during the first 18-months of life was inadequate, placing
children at increased risk of acquiring vaccine preventable
infections during infancy and childhood. High quality
trials, conducted in several settings to account for the
diversity of Australian Indigenous communities are ur-
gently needed to identify culturally appropriate, effect-
ive and sustainable strategies to improve immunisation
targets in children.
This will also assist in highlighting subpopulations
most in need of improvement and in monitoring
change over time. Our data suggest that families with
multiple children, low income or when the mother is
unemployed should be specifically targeted for inter-
ventions such as intensive follow-up, home visiting
and other support mechanisms. Further research needs
to be conducted into the extent and cause of fragmen-
ted vaccine administration, as well as predictors of de-
layed receipt in a larger study.Abbreviations
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